KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Rigel Pharmaceuticals (RIGL) Cost of Revenue (2018 - 2025)

Rigel Pharmaceuticals has reported Cost of Revenue over the past 8 years, most recently at $6.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 2.87% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $19.6 million, up 5.22%, while the annual FY2025 figure was $19.6 million, 5.22% up from the prior year.
  • Cost of Revenue for Q4 2025 was $6.0 million at Rigel Pharmaceuticals, up from $4.8 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $8.0 million in Q3 2024 and troughed at $121000.0 in Q1 2022.
  • A 5-year average of $2.4 million and a median of $1.2 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: plummeted 61.71% in 2022 and later surged 1008.19% in 2023.
  • Year by year, Cost of Revenue stood at $487000.0 in 2021, then decreased by 29.77% to $342000.0 in 2022, then surged by 1008.19% to $3.8 million in 2023, then surged by 52.74% to $5.8 million in 2024, then grew by 2.87% to $6.0 million in 2025.
  • Business Quant data shows Cost of Revenue for RIGL at $6.0 million in Q4 2025, $4.8 million in Q3 2025, and $4.5 million in Q2 2025.